生命科学工具的全球市场 - 市场规模,占有率,成长分析:各产品类型,各终端用户 - 产业预测(2022年~2028年)
市场调查报告书
商品编码
1270676

生命科学工具的全球市场 - 市场规模,占有率,成长分析:各产品类型,各终端用户 - 产业预测(2022年~2028年)

Global Life Science Tool Market Size, Share, Growth Analysis, By Product Type(PCR & QPCR, Separation Technologies), By End-User(Healthcare, Biopharmaceutical) - Industry Forecast 2022-2028

出版日期: | 出版商: SkyQuest | 英文 248 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球生命科学工具的市场规模预测将从2022年的1,440亿8,000万美元到2030年达到3,306亿9,000万美元,在预测期间(2023年~2030年)时预计将以年复合成长率10.8%的速度成长。产业成长的主要因素有研究开发活动的活跃,技术的进步,对个人化医疗的需求提高。

本报告提供全球生命科学工具市场相关调查分析,提供市场动态及预测,市场区隔分析,企业简介等资讯。

目录

摘要整理

调查手法

母市场分析

主要市场的考察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • IP分析
  • 贸易分析
  • Start-Ups分析
  • 原料的分析
  • 革新矩阵
  • 开发中产品的分析
  • 宏观经济指标
  • 主要的投资的分析
  • 主要的成功因素
  • 竞争的程度

市场动态及预测

  • 市场动态
  • 促进因素
  • 机会
  • 阻碍因素
  • 课题
  • 法规形势
  • 波特的五力分析
  • 关于未来混乱的特别见解

全球生命科学工具市场:各产品类型

  • 市场概要
  • PCR·QPCR
  • 分离技术
  • 核酸微阵列
  • 其他技术

全球生命科学工具市场:各终端用户

  • 市场概要
  • 医疗
  • 生物医药品
  • 学术
  • 政府
  • 其他

全球生命科学工具的市场规模:各地区

  • 市场概要
  • 北美
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 其他的欧洲
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他的亚太地区
  • 南美
  • 巴西
  • 其他的南美
  • 中东·非洲
  • GCC各国
  • 南非
  • 其他的中东·非洲

竞争情形

  • 前五名公司的比较
  • 主要企业的市场定位(2021年)
  • 主要市场企业采用的策略
  • 主要的成功策略
  • 市场上最近的活动
  • 主要企业的市场占有率(2021年)

主要企业简介

  • PerkinElmer Inc. (US)
  • General Electric Company (US)
  • Danaher (US)
  • Thermo Fisher Scientific (US)
  • Agilent Technologies Inc. (US)
  • Qiagen (Germany)
  • Shimadzu Corporation (Japan)
  • Becton Dickinson and Company (US)
  • Merck KGAA (Germany)
简介目录
Product Code: SQSG35J2006

Life Science Tool Market size was valued at USD 130 billion in 2021 and is poised to grow from USD 144.08 billion in 2022 to USD 330.69 billion by 2030, growing at a CAGR of 10.8% in the forecast period (2023-2030).

The global life science tool market is a rapidly growing industry that provides scientific researchers with essential equipment and technology needed for a variety of applications, such as genomics, proteomics, and drug discovery. The market includes a range of products and services, such as instruments, reagents, software, and lab services. This industry is driven by increasing research and development activities, technological advancements, and the rising demand for personalized medicine. The market is expected to continue its growth trajectory in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of Life Science Tool market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The Life Science Tool market has been segmented based on product2 type, end-user, and region. By product type, the market is segmented as PCR & qPCR, separation technologies, nucleic acid microarray, and other technologies. Based on the end-user are classified as healthcare, biopharmaceutical, academics and government, and Others. Based on region, Life Science Tool is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The life science instruments market is experiencing notable growth due to the rapid technological advancements made by businesses in fields such as sequencing technologies, mass spectrometry, NMR, and chromatography methods, among others. Market players are also increasing their investments in research and development for products and services related to life sciences, while simultaneously entering into more strategic agreements, further driving innovation and growth in the market.

Restrain

The life science software market faces obstacles that are impeding its growth, including expensive implementation costs, complex programming requirements, infrastructure demands, and the costs of managing data.

Trend

The straightforward approval processes for a range of life science tools, in contrast to medicines and medical devices, are expected to benefit the market in the near future. This will result in an abundance of life science tools available in the market, which can help combat the widespread occurrence of infectious diseases. These instruments are crucial in identifying, comprehending, and monitoring disease progression, and are expected to drive the global market in the coming years. Furthermore, ongoing technological advancements and enhancements in the production of life science tools are also expected to promote the growth of the global market.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune
  • Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
  • Market Dynamics & Outlook
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Life Science Tool Market by Product Type
  • Market Overview
  • PCR & QPCR
  • Separation Technologies
  • Nucleic Acid Microarray
  • Other Technologies
  • Global Life Science Tool Market by End-User
  • Market Overview
  • Healthcare
  • Biopharmaceutical
  • Academics
  • Government
  • Others
  • Global Life Science Tool Market Size by Region
  • Market Overview
  • North America
  • USA
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
  • By Development
  • By Company
  • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
  • Key Company Profiles
  • PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • General Electric Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Agilent Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Qiagen (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Becton Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Merck KGAA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments